Autopsy report · NCT06496477
Light Therapy to Treat Depression in Pediatric Stem Cell Therapy Recipients
Cause of deathSlow enrollment, also regulatory or ethics
“The study did not enroll participants and had not shown significant progress since the initial IRB approval.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- St. Jude Children's Research Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Hematopoietic Stem Cell Transplant
- Interventions
- Ayo wearable
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Real-time 3-Dimensional Echocardiography for Assessment of Cardiac Function and Congenital Heart Disease
“Study did not receive IRB approval.” - Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral
“Study was never initiated. No IRB approval obtained, and no participants enrolled.” - Retroperitoneal Ligation of Uterine Artery in Total Laparoscopic Hysterectomy for Enlarged Uterus
“IRB did not approve this study.” - Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
“This study was never submitted to the IRB for review and approval. No research subjects were enrolled. .” - Robotic Versus Open Comparison in the Surgical Treatment of Wide Abdominal Wall heRnias (ROCSTAR)
“The study was not initiated and no participants were enrolled.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.